Skip to main content
PMC home page
Heart logoLink to Heart
. 1998 Aug;80(2):134–140. doi: 10.1136/hrt.80.2.134

Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II

D Newby 1, N Goodfield 1, A Flapan 1, N Boon 1, K Fox 1, D Webb 1
PMCID: PMC1728788  PMID: 9813557

Abstract

Objective—To determine directly the contribution of angiotensin II to basal and sympathetically stimulated peripheral arteriolar tone in patients with heart failure.
Design—Parallel group comparison.
Subjects—Nine patients with New York Heart Association grade II-IV chronic heart failure, and age and sex matched controls.
Interventions—Forearm plethysmography, lower body negative pressure, local intra-arterial administration of losartan, angiotensin II, and noradrenaline, and estimation of plasma hormone concentrations.
Main outcome measures—Forearm blood flow responses, plasma hormone concentrations.
Results—Baseline blood pressure, heart rate, and forearm blood flow did not differ between patients and controls. In comparison with the non-infused forearm, losartan did not affect basal forearm blood flow (95% confidence interval −5.5% to +7.3%) or sympathetically stimulated vasoconstriction in controls. However, the mean (SEM) blood flow in patients increased by 13(5)% and 26(7)% in response to 30 and 90 µg/min of losartan respectively (p < 0.001). Lower body negative pressure caused a reduction in forearm blood flow of 20(5)% in controls (p = 0.008) and 13(5)% (p = 0.08) in patients (p = 0.007, controls v patients). Blood flow at 90 µg/min of losartan correlated with plasma angiotensin II concentration (r = 0.77; p = 0.03). Responses to angiotensin II and noradrenaline did not differ between patients and controls.
Conclusions—Losartan causes acute local peripheral arteriolar vasodilatation in patients with heart failure but not in healthy control subjects. Endogenous angiotensin II directly contributes to basal peripheral arteriolar tone in patients with heart failure but does not augment sympathetically stimulated peripheral vascular tone.

 Keywords: angiotensin II;  heart failure;  peripheral vascular tone;  sympathetic nervous system

Full Text

The Full Text of this article is available as a PDF (160.8 KB).

Figure 1  .

Figure 1  

Open in a new tab

Absolute (non-infused arm, squares; infused arm, triangles) and percentage change in forearm blood flow responses (circles), with intermittent application (arrows) of lower body negative pressure (LBNP), to saline and losartan (30 and 90 µg/min) infusion in healthy control subjects (empty symbols) and patients with heart failure (filled symbols). *p < 0.001 (one way ANOVA, v baseline saline infusion); †p = 0.008 (two way ANOVA, basal v LBNP).

Figure 2  .

Figure 2  

Open in a new tab

Forearm blood flow responses to infusion of angiotensin II (squares) and noradrenaline (circles) in healthy control subjects (empty symbols) and patients with heart failure (filled symbols); p < 0.001 (one way ANOVA for each response).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baan J., Jr, Chang P. C., Vermeij P., Pfaffendorf M., van Zwieten P. A. Effects of losartan on vasoconstrictor responses to angiotensin II in the forearm vascular bed of healthy volunteers. Cardiovasc Res. 1996 Nov;32(5):973–979. [PubMed] [Google Scholar]
  2. Benjamin N., Calver A., Collier J., Robinson B., Vallance P., Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension. 1995 May;25(5):918–923. doi: 10.1161/01.hyp.25.5.918. [DOI] [PubMed] [Google Scholar]
  3. Brough R. B., Jr, Cowley A. W., Jr, Guyton A. C. Quantitative analysis of the acute response to haemorrhage of the renin-angiotensin-vasoconstrictor feedback loop in areflexic dogs. Cardiovasc Res. 1975 Nov;9(6):722–733. doi: 10.1093/cvr/9.6.722. [DOI] [PubMed] [Google Scholar]
  4. Clemson B., Gaul L., Gubin S. S., Campsey D. M., McConville J., Nussberger J., Zelis R. Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm. J Clin Invest. 1994 Feb;93(2):684–691. doi: 10.1172/JCI117021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cockcroft J. R., O'Kane K. P., Webb D. J. Tissue angiotensin generation and regulation of vascular tone. Pharmacol Ther. 1995 Feb;65(2):193–213. doi: 10.1016/0163-7258(94)00062-8. [DOI] [PubMed] [Google Scholar]
  6. Cody R. J., Haas G. J., Binkley P. F., Capers Q., Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation. 1992 Feb;85(2):504–509. doi: 10.1161/01.cir.85.2.504. [DOI] [PubMed] [Google Scholar]
  7. Cohn J. N., Archibald D. G., Ziesche S., Franciosa J. A., Harston W. E., Tristani F. E., Dunkman W. B., Jacobs W., Francis G. S., Flohr K. H. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Jun 12;314(24):1547–1552. doi: 10.1056/NEJM198606123142404. [DOI] [PubMed] [Google Scholar]
  8. Cohn J. N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W. B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303–310. doi: 10.1056/NEJM199108013250502. [DOI] [PubMed] [Google Scholar]
  9. Creager M. A., Massie B. M., Faxon D. P., Friedman S. D., Kramer B. L., Weiner D. A., Ryan T. J., Topic N., Melidossian C. D. Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure. J Am Coll Cardiol. 1985 Jul;6(1):163–173. doi: 10.1016/s0735-1097(85)80269-2. [DOI] [PubMed] [Google Scholar]
  10. Crozier I., Ikram H., Awan N., Cleland J., Stephen N., Dickstein K., Frey M., Young J., Klinger G., Makris L. Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group. Circulation. 1995 Feb 1;91(3):691–697. doi: 10.1161/01.cir.91.3.691. [DOI] [PubMed] [Google Scholar]
  11. Dickstein K., Chang P., Willenheimer R., Haunsø S., Remes J., Hall C., Kjekshus J. Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure. J Am Coll Cardiol. 1995 Aug;26(2):438–445. doi: 10.1016/0735-1097(95)80020-h. [DOI] [PubMed] [Google Scholar]
  12. Ferguson D. W., Abboud F. M., Mark A. L. Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction. Circulation. 1984 Mar;69(3):451–460. doi: 10.1161/01.cir.69.3.451. [DOI] [PubMed] [Google Scholar]
  13. Goldsmith S. R., Rector T. S., Bank A. J., Garr M., Kubo S. H. Effect of angiotensin II on noradrenaline release in the human forearm. Cardiovasc Res. 1994 May;28(5):663–666. doi: 10.1093/cvr/28.5.663. [DOI] [PubMed] [Google Scholar]
  14. Goldstein D. S., Feuerstein G., Izzo J. L., Jr, Kopin I. J., Keiser H. R. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci. 1981 Feb 2;28(5):467–475. doi: 10.1016/0024-3205(81)90139-9. [DOI] [PubMed] [Google Scholar]
  15. Gottlieb S. S., Dickstein K., Fleck E., Kostis J., Levine T. B., LeJemtel T., DeKock M. Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure. Circulation. 1993 Oct;88(4 Pt 1):1602–1609. doi: 10.1161/01.cir.88.4.1602. [DOI] [PubMed] [Google Scholar]
  16. Groves P., Kurz S., Just H., Drexler H. Role of endogenous bradykinin in human coronary vasomotor control. Circulation. 1995 Dec 15;92(12):3424–3430. doi: 10.1161/01.cir.92.12.3424. [DOI] [PubMed] [Google Scholar]
  17. Haynes W. G., Webb D. J. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet. 1994 Sep 24;344(8926):852–854. doi: 10.1016/s0140-6736(94)92827-4. [DOI] [PubMed] [Google Scholar]
  18. Hjemdahl P., Friberg P. Biochemical assessment of sympathetic activity and prejunctional modulation of noradrenaline release in humans. J Hypertens. 1996 Feb;14(2):147–150. doi: 10.1097/00004872-199602000-00001. [DOI] [PubMed] [Google Scholar]
  19. Johnston C. I. Angiotensin receptor antagonists: focus on losartan. Lancet. 1995 Nov 25;346(8987):1403–1407. doi: 10.1016/s0140-6736(95)92411-6. [DOI] [PubMed] [Google Scholar]
  20. Kluger J., Cody R. J., Laragh J. H. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril). Am J Cardiol. 1982 May;49(7):1667–1674. doi: 10.1016/0002-9149(82)90244-2. [DOI] [PubMed] [Google Scholar]
  21. Leimbach W. N., Jr, Wallin B. G., Victor R. G., Aylward P. E., Sundlöf G., Mark A. L. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation. 1986 May;73(5):913–919. doi: 10.1161/01.cir.73.5.913. [DOI] [PubMed] [Google Scholar]
  22. Levine T. B., Francis G. S., Goldsmith S. R., Cohn J. N. The neurohumoral and hemodynamic response to orthostatic tilt in patients with congestive heart failure. Circulation. 1983 May;67(5):1070–1075. doi: 10.1161/01.cir.67.5.1070. [DOI] [PubMed] [Google Scholar]
  23. Levine T. B., Francis G. S., Goldsmith S. R., Simon A. B., Cohn J. N. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol. 1982 May;49(7):1659–1666. doi: 10.1016/0002-9149(82)90243-0. [DOI] [PubMed] [Google Scholar]
  24. Levine T. B., Olivari M. T., Garberg V., Sharkey S. W., Cohn J. N. Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure. Circulation. 1984 Mar;69(3):548–553. doi: 10.1161/01.cir.69.3.548. [DOI] [PubMed] [Google Scholar]
  25. MacGregor G. A. Dietary salt and blood pressure. Lancet. 1994 Feb 26;343(8896):545–545. [PubMed] [Google Scholar]
  26. Morton J. J., Webb D. J. Measurement of plasma angiotensin II. Clin Sci (Lond) 1985 Apr;68(4):483–484. doi: 10.1042/cs0680483. [DOI] [PubMed] [Google Scholar]
  27. Newby D. E., Masumori S., Johnston N. R., Boon N. A., Webb D. J. Endogenous angiotensin II contributes to basal peripheral vascular tone in sodium deplete but not sodium replete man. Cardiovasc Res. 1997 Nov;36(2):268–275. doi: 10.1016/s0008-6363(97)00171-5. [DOI] [PubMed] [Google Scholar]
  28. Nishian K., Kawashima S., Iwasaki T. Paradoxical forearm vasodilatation and haemodynamic improvement during cardiopulmonary baroreceptor unloading in patients with congestive heart failure. Clin Sci (Lond) 1993 Mar;84(3):271–280. doi: 10.1042/cs0840271. [DOI] [PubMed] [Google Scholar]
  29. Pitt B., Segal R., Martinez F. A., Meurers G., Cowley A. J., Thomas I., Deedwania P. C., Ney D. E., Snavely D. B., Chang P. I. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) Lancet. 1997 Mar 15;349(9054):747–752. doi: 10.1016/s0140-6736(97)01187-2. [DOI] [PubMed] [Google Scholar]
  30. Rolinski B., Sadri I., Bogner J., Goebel F. D. Determination of endothelin-1 immunoreactivity in plasma, cerebrospinal fluid and urine. Res Exp Med (Berl) 1994;194(1):9–24. doi: 10.1007/BF02576362. [DOI] [PubMed] [Google Scholar]
  31. Seidelin P. H., Collier J. G., Struthers A. D., Webb D. J. Angiotensin II augments sympathetically mediated arteriolar constriction in man. Clin Sci (Lond) 1991 Aug;81(2):261–266. doi: 10.1042/cs0810261. [DOI] [PubMed] [Google Scholar]
  32. Taddei S., Virdis A., Mattei P., Favilla S., Salvetti A. Angiotensin II and sympathetic activity in sodium-restricted essential hypertension. Hypertension. 1995 Apr;25(4 Pt 1):595–601. doi: 10.1161/01.hyp.25.4.595. [DOI] [PubMed] [Google Scholar]
  33. Vallance P., Collier J., Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989 Oct 28;2(8670):997–1000. doi: 10.1016/s0140-6736(89)91013-1. [DOI] [PubMed] [Google Scholar]
  34. Webb D. J. The pharmacology of human blood vessels in vivo. J Vasc Res. 1995 Jan-Feb;32(1):2–15. doi: 10.1159/000159072. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES